MOTILITY-ASSOCIATED PROTEINS IN OVARIAN CANCER: RELATION WITH CLINICAL-MORPHOLOGICAL PARAMETERS AND NEOADJUVANT CHEMOTHERAPY RESPONSE

MOTILITY-ASSOCIATED PROTEINS IN OVARIAN CANCER: RELATION WITH CLINICAL-MORPHOLOGICAL PARAMETERS AND NEOADJUVANT CHEMOTHERAPY RESPONSE

The expression of motility-associated proteins in 18 patients with epithelial ovarian cancer was investigated. The study of actin-binding proteins (Arp3, gelsolin, cofilin-1 and thymosin-β4) and p45 Ser β-catenin revealed peculiarities of their expression with respect to clinicalmorphological parame...

Full description

Saved in:

Bibliographic Details
Main Authors:	N. V. Yunusova, I. V. Kondakova, L. A. Kolomiets, T. V. Tropina, A. B. Villert, O. V. Spilyeva, V. D. Koval
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2016-02-01
Series:	Сибирский онкологический журнал
Subjects:	motility-associated proteins ovarian cancer omentum metastasis peritoneal metastasis neoadjuvant chemotherapy
Online Access:	https://www.siboncoj.ru/jour/article/view/127
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The group of hypermethylated long noncoding RNA genes is associated with different types of metastasis in ovarian cancer
by: Alexey M. Burdenny, et al.
Published: (2024-09-01)

Patients with macroscopic lymph node metastasis expect poor prognosis after neoadjuvant chemotherapy in advanced ovarian cancer: a retrospective cohort study based on a single gynecological team
by: Wen Guo, et al.
Published: (2025-05-01)

The Controversy of Intraperitoneal Hyperthermic Chemotherapy for Ovarian Cancer
by: Lucian ALECU, et al.
Published: (2020-12-01)

PROTEASOMES AND EXOSOMES IN OVARIAN CANCER: RALATION WITH DISEASE PROGNOSIS AND CLINICAL OUTCOME
by: N. V. Yunusova, et al.
Published: (2016-02-01)

[Comment] Impact of resection for ovarian metastases from colorectal cancer and clinicopathologic analysis: a multicenter retrospective study in Japan
by: Lin Yu, et al.
Published: (2024-04-01)

Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
by: S. A. Kuznetsov, et al.
Published: (2015-09-01)

NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER. MODERN METHODS AND PATIENTS SELECTION CRITERIA
by: A. E. Solopova, et al.
Published: (2016-09-01)

Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report
by: Kozo Miyatani, et al.
Published: (2020-05-01)

Neutrophil infiltration in peritoneal metastasis affects prognosis in patients with ovarian cancer
by: Emiri Miyamoto, et al.
Published: (2025-07-01)

A novel chemotherapeutic protocol for peritoneal metastasis and inhibition of relapse in drug resistant ovarian cancer
by: Siddik Sarkar, et al.
Published: (2018-08-01)

Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
by: Upasana Baruah, et al.
Published: (2015-01-01)

Current Status and Controversies in Neoadjuvant Chemotherapy for Advanced Stage Ovarian Cancer: A Review
by: Jiaxi Li, et al.
Published: (2023-11-01)

THE GREATER OMENTUM IN WOMEN WITH OVARIAN CANCER
by: L. V. Khalikova
Published: (2017-02-01)

The impact of multiple neoadjuvant chemotherapy cycles in patients with advanced epithelial ovarian cancer: A single center experience
by: Wala Mehros, et al.
Published: (2025-01-01)

DISSEMINATED OVARIAN CANCER: MODERN APPROACH TO DRUG THERAPY (REVIEW OF PUBLISHED LITERATURE)
by: S. V. Molchanov, et al.
Published: (2016-02-01)

Upfront surgery, neoadjuvant chemoradiotherapy, or neoadjuvant chemotherapy for rectal cancer with lateral lymph node metastasis: A multicenter MRI and lateral lymph node dissection study
by: Takuya Miura, et al.
Published: (2025-03-01)

New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
by: Chuying Huo, et al.
Published: (2024-12-01)

Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review)
by: E. V. Sibirskaya, et al.
Published: (2024-05-01)

Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis
by: Yuxi Ma, et al.
Published: (2025-06-01)

Low Visceral Adipose Tissue Predicts the Outcome of Neoadjuvant Chemotherapy for Colorectal Liver Metastases: A Multicentre Real‐World Study
by: Yizhen Chen, et al.
Published: (2025-04-01)

Combined Nabpaclitaxel pressurized intraPeritoneal aerosol chemotherapy with systemic Nabpaclitaxel-Gemcitabine chemotherapy for pancreatic cancer peritoneal metastases: protocol of single-arm, open-label, phase II trial (Nab-PIPAC trial)
by: Di Giorgio Andrea, et al.
Published: (2024-11-01)

Adipose tissue loss during neoadjuvant chemotherapy: a key prognostic factor in advanced epithelial ovarian cancer
by: Wassim Benouali, et al.
Published: (2025-03-01)

Restriction of YWHAB-mediated YAP cytoplasmic retention is a novel mechanism underlying stemness maintenance and chemoresistance in ovarian cancer peritoneal metastasis
by: Chang Liu, et al.
Published: (2025-09-01)

Clinical efficacy analysis of chemotherapy of isolated neck lymphatic metastasis in advanced epithelial ovarian cancer
by: Hong Liu, et al.
Published: (2025-05-01)

The predictive role of PD-L1 expression and CD8 + TIL levels in determining the neoadjuvant chemotherapy response in advanced ovarian cancer
by: T. Aliyeva, et al.
Published: (2024-11-01)

CELLULAR IMMUNE REACTION IN A GREAT OMENTUM WITH METASTASES IN PATIENTS WITH OVARIAN CANCER
by: L. V. Khalikova, et al.
Published: (2018-08-01)

Immune mechanisms in the pathogenesis of acute peritonitis G.V. Bulava
by: G. V. Bulava
Published: (2023-03-01)

Ovarian adenocarcinoma in a young female with skin and umbilical metastasis
by: Shukla Pragya, et al.
Published: (2009-12-01)

Perspectives of pressurized intraperitoneal aerosol chemotherapy in terms of primary ovarian cancer with peritoneal carcinomatosis treatment
by: A. S. Dzasokhov, et al.
Published: (2023-03-01)

Ascites as a subject of studies in ovarian cancer
by: A. B. Villert, et al.
Published: (2019-02-01)

Comparison of outcomes of neoadjuvant chemotherapy in BRCA1- versus BRCA2-associated breast and ovarian cancers
by: Anna Sokolenko, et al.
Published: (2025-06-01)

Efficacy and safety analyses of bevacizumab in neoadjuvant chemotherapy for ovarian cancer: a systematic review and meta-analysis
by: Yijun Wang, et al.
Published: (2025-05-01)

An agarose spot assay for chemotactic invasion
by: Helen L. Wiggins, et al.
Published: (2010-02-01)

Ewing's Sarcoma Omental Odyssey: Unraveling Rare Metastasis and Unforeseen Treatment Outcome on FDG PET/CT: Case Report with Review of Literature
by: Prakash Singh, et al.

Neoadjuvant chemotherapy of invasive bladder cancer
by: S. N. Isayeva, et al.
Published: (2012-04-01)

Pressurized intraperitoneal aerosolized chemotherapy clinical efficacy in the combined treatment of newly diagnosed ovarian cancer with peritoneal carcinomatosis and ascites
by: A. S. Dzasochov, et al.
Published: (2024-12-01)

NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER
by: O. N. Churuksaeva, et al.
Published: (2016-02-01)

Coalescing Papules on the Pubis in an Ovarian Carcinoma: A Quiz
by: Pauline Hirtz, et al.
Published: (2025-05-01)

Neoadjuvant Chemotherapy With Cisplatin Up‐Regulates GSDMD to Enhance Oral Squamous Cell Carcinoma Metastasis Through MMP14‐Mediated EMT Activation
by: Zixian Huang, et al.
Published: (2025-07-01)

Pathological complete response after intraperitoneal paclitaxel and systemic combined chemotherapy in a patient with peritoneal metastases from gastric cancer: a case report
by: Yoshiyuki Meguro, et al.
Published: (2020-03-01)